UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...

The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...

Asthma a chronic respiratory condition may be driven by specific immune cells that influence inflammation and severity ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...

By providing our partners with the right technology platform, as well as scientific, technical and regulatory support ... and commercialization of novel treatments for B-cell diseases. In addition to ...

As part of the partnership, ASCI has flagged 413 offshore betting ads to the MIB and reviewed 12 real-money gaming ads for ...

C3i Center (C3i) announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the ...